SPDR S&P Biotech ETF (XBI) - News Mentions

Sign up to add (XBI) to your portfolio and access more historical data.

00%
Est. daily news mentions.

Sign up to access historical data

Sign up

Similar companies

Company News Mentions
SPDR S&P 500 ETF
SPDR S&P 500 ETF
SPY		 513 2.8%
Invesco QQQ
Invesco QQQ
QQQ		 0 100%
Vanguard Total Stock Market Index
Vanguard Total Stock Market Index
VTI		 0 0%
Technology Select Sector SPDR
Technology Select Sector SPDR
XLK		 0 0%
SPDR Gold Shares
SPDR Gold Shares
GLD		 0 100%
SPDR S&P Biotech ETF (NYSEARCA:XBI) Shares Bought by Sigma Planning Corp
November 13
Janney Montgomery Scott LLC Sells 14,603 Shares of SPDR S&P Biotech ETF (NYSEARCA:XBI)
November 8
Focus Financial Network Inc. Acquires Shares of 2,207 SPDR S&P Biotech ETF (NYSEARCA:XBI)
November 4
SPDR S&P Biotech ETF (NYSEARCA:XBI) Position Reduced by Pinnacle Associates Ltd.
November 3
Wealth Enhancement Advisory Services LLC Increases Holdings in SPDR S&P Biotech ETF (NYSEARCA:XBI)
October 30
XBI, ALNY, UTHR, EXAS: ETF Outflow Alert
October 28
Grimes & Company Inc. Acquires New Holdings in SPDR S&P Biotech ETF (NYSEARCA:XBI)
October 26
Private Advisor Group LLC Has $22.22 Million Stock Position in SPDR S&P Biotech ETF (NYSEARCA:XBI)
October 24
XBI: Biotech ETF Is A Must Have
October 24
NBC Securities Inc. Sells 220 Shares of SPDR S&P Biotech ETF (NYSEARCA:XBI)
October 18
Analysts See 47% Upside For XBI
October 17
ORG Wealth Partners LLC Invests $44,000 in SPDR S&P Biotech ETF (NYSEARCA:XBI)
October 16
Noteworthy ETF Outflows: XBI, UTHR, EXAS, NTRA
October 15
Atomi Financial Group Inc. Cuts Stock Position in SPDR S&P Biotech ETF (NYSEARCA:XBI)
October 14
SPDR S&P Biotech ETF (NYSEARCA:XBI) Shares Bought by GAMMA Investing LLC
October 14
Look Under The Hood: XBI Has 52% Upside
October 9

Month over Month

Est. daily news mentions.

Oct 2024 0
Sep 2024 0
Aug 2024 0
Jul 2024 0
Jun 2024 0

How often is SPDR S&P Biotech ETF mentioned in the news?

SPDR S&P Biotech ETF was mentioned an estimated 0 times in online prominent news articles yesterday.

Analyzing News Mentions, how is SPDR S&P Biotech ETF performing compared to its industry peers?

SPDR S&P Biotech ETF underperforms its industry peers when it comes to News Mentions, ranking dead last.

Has there been an increase or decrease in news mentions of SPDR S&P Biotech ETF in the last month?

There has been no significant change in the number of news mentions for SPDR S&P Biotech ETF's compared to the last month.

Why is it important to track news mentions for SPDR S&P Biotech ETF?

By monitoring mentions in the news for SPDR S&P Biotech ETF, investors stay up to date on impactful events for the company, its industry and its competitors. Positive news might affect price in a positive way and negative news might affect price in a negative way. By tracking mentions over time, investors can also identify patterns, explore popularity and make informed decisions based on the evolving perception of SPDR S&P Biotech ETF, ultimately improving their investment strategies.

Sign up and get more insights on SPDR S&P Biotech ETF.

The analytics provided are estimates and not a substitute for professional advice. All investments involve risks, including possible capital loss.
About Us

AltIndex revolutionizes investing with advanced alternative data analytics, smart insights, and stock alerts, presented in an easy-to-use dashboard powered by comprehensive company data from across the internet.



App download

Legal Disclaimer
The information provided by AltIndex is solely for informational purposes and not a substitute for professional financial advice. Investing in financial markets carries inherent risks, and past performance doesn't guarantee future results. It's crucial to do your research, consult with financial experts, and align your financial objectives and risk tolerance before investing. AltIndex creators and operators are not liable for any financial losses incurred from using this information. Users should exercise caution, seek professional advice, and be prepared for the risks involved in trading and investing in financial assets, only investing what they can afford to lose. The information in this application, derived from publicly available data, is believed to be reliable but may not always be accurate or current. Users should verify information independently and not solely rely on this application for financial decisions. By using AltIndex, you acknowledge that it doesn't offer financial advice and agree to consult a qualified financial advisor before making investment decisions.

© 2024 AltIndex. All rights reserved.

Top Stocks

Trending Stocks
Trending Stocks on WallStreetBets
Trending Stocks on Reddit
Top Stocks
Top Stock Performers Today
Bottom Stock Performers Today
Best Airlines Stocks
Best Bank Stocks
Best Semiconductor Stocks
Best Energy Stocks
Best Fintech Stocks
Best Robotics Stocks
Best Insurance Stocks

Our Data

Datasets
Stock alerts
AI Stock Picks
AI Stock Picks - Results
Fear & Greed Index
Meme Stocks
Threads Users
Stock Predictor
Stock Picking Reviews
Stock Trading Signals
House & Congress Trading
Earnings Calendar
Index

AltIndex

News
Pricing
Sign up
Log in
API
Journalist Access
Data Disclaimer
Contact